The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials
Open accessAbstract
Amyotrophic lateral sclerosis (ALS), first described by Jean-Martin Charcot in the 1870s, is an age-related disorder that leads to degeneration of motor neurons. The disease begins focally in the central nervous system and then spreads relentlessly. The clinical diagnosis, defined by progressive signs and symptoms of upper and lower motor neuron dysfunction, is confirmed by electromyography. Additional testing excludes other conditions. The disease is heterogeneous, but most patients die of respiratory muscle weakness less than 3 years from symptom-onset. Like other age-related neurodegenerative diseases, ALS has genetic and environmental triggers. Of the five to 10% of cases that are inherited, mutations have been discovered for a high proportion. In addition to genetic factors, age, tobacco use, and athleticism may contribute to sporadic ALS, but important etiologies are unidentified for most patients. Complex pathophysiological processes, including mitochondrial dysfunction, aggregation of misfolded protein, oxidative stress, excitotoxicity, inflammation and apoptosis, involve both motor neurons and surrounding glial cells. There is clinical and pathological overlap with other neurodegenerative diseases, particularly frontotemporal dementia. The mechanisms leading to disease propagation in the brain are a current focus of research. To date, one medication, riluzole, licensed in 1996, has been proved to prolong survival in ALS. Numerous clinical trials have so far been unable to identify another neuroprotective agent. Researchers now aim to slow disease progression by targeting known pathophysiological pathways or genetic defects. Current approaches are directed at muscle proteins such as Nogo, energetic balance, cell replacement, and abnormal gene products resulting from mutations. Until better understanding of the causes and mechanisms underlying progression lead to more robust neuroprotective agents, symptomatic therapies can extend life and improve quality of life. Palliative care programs such as hospice give emotional and physical support to patients and families throughout much of the disease course.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,553
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,233
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,812
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262204 · Cited by 1,177
Prognostic factors in ALS: A critical review
Chiò, A., Logroscino, G., Hardiman, O., Swingler, R., Mitchell, D., Beghi, E., Traynor, B. G., & On Behalf of the Eurals Consortium (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802566824 · Cited by 1,172
Bourke, S. C., Tomlinson, M., Williams, T. L., Bullock, R. E., Shaw, P. J., & Gibson, G. J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70326-4 · Cited by 1,171
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., & Moore, D. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub3 · Cited by 1,058
Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992
Rosen, D. (1993) · Nature · doi:10.1038/364362c0 · Cited by 922
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R., Mitchell, J., Lyon, M., & Moore, D. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447 · Cited by 909
Miller, R. G., Jackson, C. E., Kasarskis, E. J., England, J. D., Forshew, D., Johnston, W., Kalra, S., Katz, J. S., Mitsumoto, H., Rosenfeld, J., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc0141 · Cited by 807
Incidence of amyotrophic lateral sclerosis in Europe
Logroscino, G., Traynor, B. J., Hardiman, O., Chio, A., Mitchell, D., Swingler, R. J., Millul, A., Benn, E., Beghi, E., & EURALS, F. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.183525 · Cited by 772
Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
Rothstein, J. D. (2009) · Annals of Neurology · doi:10.1002/ana.21543 · Cited by 703
Clinical genetics of amyotrophic lateral sclerosis: what do we really know?
Andersen, P. M., & Al-Chalabi, A. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.150 · Cited by 687
Miller, R. G., Jackson, C. E., Kasarskis, E. J., England, J. D., Forshew, D., Johnston, W., Kalra, S., Katz, J. S., Mitsumoto, H., Rosenfeld, J., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc01a4 · Cited by 674
Are amyotrophic lateral sclerosis patients cognitively normal?
Lomen-Hoerth, C., Murphy, J., Langmore, S., Kramer, J. H., Olney, R. K., & Miller, B. (2003) · Neurology · doi:10.1212/01.wnl.0000055861.95202.8d · Cited by 620
Miller, T. M., Pestronk, A., David, W., Rothstein, J., Simpson, E., Appel, S. H., Andres, P. L., Mahoney, K., Allred, P., Alexander, K., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70061-9 · Cited by 617
Traynor, B. J. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1258 · Cited by 493
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players
Chio, A. (2005) · Brain · doi:10.1093/brain/awh373 · Cited by 484
Byrne, S., Elamin, M., Bede, P., Shatunov, A., Walsh, C., Corr, B., Heverin, M., Jordan, N., Kenna, K., Lynch, C., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70014-5 · Cited by 484
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
Logroscino, G., Traynor, B. J., Hardiman, O., Chio', A., Couratier, P., Mitchell, J. D., Swingler, R. J., Beghi, E., & EURALS, F. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.104828 · Cited by 448
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: A randomized trial
Brooks, B. R., Thisted, R. A., Appel, S. H., Bradley, W. G., Olney, R. K., Berg, J. E., Pope, L. E., & Smith, R. A. (2004) · Neurology · doi:10.1212/01.wnl.0000142042.50528.2f · Cited by 434
The natural history of primary lateral sclerosis
Gordon, P. H., Cheng, B., Katz, I. B., Pinto, M., Hays, A. P., Mitsumoto, H., & Rowland, L. P. (2006) · Neurology · doi:10.1212/01.wnl.0000200962.94777.71 · Cited by 369
Self-citationAn estimate of amyotrophic lateral sclerosis heritability using twin data
Al-Chalabi, A., Fang, F., Hanby, M. F., Leigh, P. N., Shaw, C. E., Ye, W., & Rijsdijk, F. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.207464 · Cited by 323
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
Ludolph, A. C., Bendotti, C., Blaugrund, E., Chio, A., Greensmith, L., Loeffler, J.-P., Mead, R., Niessen, H. G., Petri, S., Pradat, P.-F., et al. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903545334 · Cited by 315
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., Lyon, M., & Moore, D. H. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub2 · Cited by 313
Millecamps, S., Salachas, F., Cazeneuve, C., Gordon, P., Bricka, B., Camuzat, A., Guillot-Noël, L., Russaouen, O., Bruneteau, G., Pradat, P.-F., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2010.077180 · Cited by 311
Self-citationKasarskis, E., Berryman, S., Vanderleest, J., Schneider, A., & McClain, C. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.1.130 · Cited by 293
Variants of the elongator protein 3 ( ELP3 ) gene are associated with motor neuron degeneration
Simpson, C. L., Lemmens, R., Miskiewicz, K., Broom, W. J., Hansen, V. K., van Vught, P. W. J., Landers, J. E., Sapp, P., Van Den Bosch, L., Knight, J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn375 · Cited by 291
Marin, B., Desport, J. C., Kajeu, P., Jesus, P., Nicolaud, B., Nicol, M., Preux, P. M., & Couratier, P. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.211474 · Cited by 284
A randomized sequential trial of creatine in amyotrophic lateral sclerosis
Jan Groeneveld, G., Veldink, J. H., van der Tweel, I., Kalmijn, S., Beijer, C., de Visser, M., Wokke, J. H. J., Franssen, H., & Berg, L. H. V. D. (2003) · Annals of Neurology · doi:10.1002/ana.10554 · Cited by 283
Occurrence of amyotrophic lateral sclerosis among Gulf War veterans
Horner, R. D., Kamins, K. G., Feussner, J. R., Grambow, S. C., Hoff-Lindquist, J., Harati, Y., Mitsumoto, H., Pascuzzi, R., Spencer, P. S., Tim, R., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000069922.32557.ca · Cited by 277
Early symptom progression rate is related to ALS outcome: A prospective population-based study
Chiò, A., Mora, G., Leone, M., Mazzini, L., Cocito, D., Giordana, M. T., Bottacchi, E., & Mutani, R. (2002) · Neurology · doi:10.1212/wnl.59.1.99 · Cited by 266
Neuroprotective agents for clinical trials in Parkinson’s disease: A systematic assessment
Ravina, B. M., Fagan, S. C., Hart, R. G., Hovinga, C. A., Murphy, D. D., Dawson, T. M., & Marler, J. R. (2003) · Neurology · doi:10.1212/01.wnl.0000058760.13152.1a · Cited by 262
The effects of executive and behavioral dysfunction on the course of ALS
Olney, R. K., Murphy, J., Forshew, D., Garwood, E., Miller, B. L., Langmore, S., Kohn, M. A., & Lomen-Hoerth, C. (2005) · Neurology · doi:10.1212/01.wnl.0000188759.87240.8b · Cited by 258
Use of Sniff Nasal-Inspiratory Force to Predict Survival in Amyotrophic Lateral Sclerosis
Morgan, R. K., McNally, S., Alexander, M., Conroy, R., Hardiman, O., & Costello, R. W. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-314oc · Cited by 250
Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis
Carvalho, M. D., & Swash, M. (2009) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802521126 · Cited by 250
Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis
Douaud, G., Filippini, N., Knight, S., Talbot, K., & Turner, M. R. (2011) · Brain · doi:10.1093/brain/awr279 · Cited by 247
Premorbid weight, body mass, and varsity athletics in ALS
Scarmeas, N., Shih, T., Stern, Y., Ottman, R., & Rowland, L. P. (2002) · Neurology · doi:10.1212/wnl.59.5.773 · Cited by 246
Louis, E. D., Mayer, S. A., & Rowland, L. P. (2001) · Cited by 243
Whole-Genome Analysis of Sporadic Amyotrophic Lateral Sclerosis
Dunckley, T., Huentelman, M. J., Craig, D. W., Pearson, J. V., Szelinger, S., Joshipura, K., Halperin, R. F., Stamper, C., Jensen, K. R., Letizia, D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070174 · Cited by 236
Occupational Exposures and Amyotrophic Lateral Sclerosis. A Population-based Case-Control Study
McGuire, V., Longstreth, W. T., Nelson, L. M., Koepsell, T. D., Checkoway, H., Morgan, M. S., & van Belle, G. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009070 · Cited by 236
Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population‐based study
Alonso, A., Logroscino, G., Jick, S. S., & Hernán, M. A. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02586.x · Cited by 229
Occurrence of amyotrophic lateral sclerosis among Gulf War veterans
Armon, C. (2007) · Neurology · doi:10.1212/01.wnl.0000260429.80237.c0 · Cited by 224
Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis
van Es, M. A., van Vught, P. W., Blauw, H. M., Franke, L., Saris, C. G., Van Den Bosch, L., de Jong, S. W., de Jong, V., Baas, F., van't Slot, R., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.52 · Cited by 214
van Es, M. A., Van Vught, P. W., Blauw, H. M., Franke, L., Saris, C. G., Andersen, P. M., Van Den Bosch, L., de Jong, S. W., van 't Slot, R., Birve, A., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70222-3 · Cited by 210
Armon, C. (2003) · Neuroepidemiology · doi:10.1159/000070562 · Cited by 209
Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998
Sorenson, E. J., Stalker, A. P., Kurland, L. T., & Windebank, A. J. (2002) · Neurology · doi:10.1212/wnl.59.2.280 · Cited by 205
Neuroprotective agents for clinical trials in ALS: A systematic assessment
Traynor, B. J., Bruijn, L., Conwit, R., Beal, F., O’Neill, G., Fagan, S. C., & Cudkowicz, M. E. (2006) · Neurology · doi:10.1212/01.wnl.0000223353.34006.54 · Cited by 193
Fatigue and depression are associated with poor quality of life in ALS
Lou, J.-S., Reeves, A., Benice, T., & Sexton, G. (2003) · Neurology · doi:10.1212/01.wnl.0000042781.22278.0a · Cited by 192
Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease
Dal Bello-Haas, V., & Florence, J. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005229.pub3 · Cited by 178
Nelson, L. M., McGuire, V., Longstreth, W. T., & Matkin, C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010183 · Cited by 174
Nogo Provides a Molecular Marker for Diagnosis of Amyotrophic Lateral Sclerosis
Dupuis, L., Gonzalez de Aguilar, J.-L., di Scala, F., Rene, F., de Tapia, M., Pradat, P.-F., Lacomblez, L., Seihlan, D., Prinjha, R., Walsh, F. S., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0522 · Cited by 172
Ravits, J., Appel, S., Baloh, R. H., Barohn, R., Rix Brooks, B., Elman, L., Floeter, M. K., Henderson, C., Lomen-Hoerth, C., Macklis, J. D., et al. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.778548 · Cited by 169
Newsom-Davis, I. C. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.482 · Cited by 169
Smoking and Risk of Amyotrophic Lateral Sclerosis: A Pooled Analysis of 5 Prospective Cohorts
Wang, H., O’Reilly, É. J., Weisskopf, M. G., Logroscino, G., McCullough, M. L., Thun, M. J., Schatzkin, A. G., Kolonel, L. N., & Ascherio, A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.367 · Cited by 168
Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review
Sutedja, N. A., Veldink, J. H., Fischer, K., Kromhout, H., Heederik, D., Huisman, M. H. B., Wokke, J. H. J., & van den Berg, L. H. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802455416 · Cited by 160
Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis and Management
Gordon, P. H. (2010) · CNS Drugs · doi:10.2165/11586000-000000000-00000 · Cited by 158
Self-citationNelson, L. M., Matkin, C. C., Longstreth, W. T., Jr., & McGuire, V. M. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010184 · Cited by 152
Xu, L., Ryugo, D. K., Pongstaporn, T., Johe, K. K., & Koliatsos, V. E. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22022 · Cited by 146
Smoking and risk for amyotrophic lateral sclerosis: Analysis of the EPIC cohort
Gallo, V., Bueno-de-Mesquita, H. B., Vermeulen, R. C. H., Andersen, P. M., Kyrozis, A., Linseisen, J., Kaaks, R., Allen, N. E., Roddam, A., Boshuizen, H. C., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21653 · Cited by 144
Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease
Lindquist, S., Duno, M., Batbayli, M., Puschmann, A., Braendgaard, H., Mardosiene, S., Svenstrup, K., Pinborg, L., Vestergaard, K., Hjermind, L., et al. (2013) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01903.x · Cited by 143
Eye-gaze independent EEG-based brain–computer interfaces for communication
Riccio, A., Mattia, D., Simione, L., Belardinelli, M. O., & Cincotti, F. (2012) · Journal of Neural Engineering · doi:10.1088/1741-2560/9/4/045001 · Cited by 143
Lifetime occupation, education, smoking, and risk of ALS
Sutedja, N. A., Veldink, J. H., Fischer, K., Kromhout, H., Wokke, J. H. J., Huisman, M. H. B., Heederik, D. J. J., & van den Berg, L. H. (2007) · Neurology · doi:10.1212/01.wnl.0000277463.87361.8c · Cited by 136
Kanouchi, T., Ohkubo, T., & Yokota, T. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301826 · Cited by 134
Prognosis of amyotrophic lateral sclerosis and the effect of referral selection
Lee, J. R.-J., Annegers, J. F., & Appel, S. H. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00154-t · Cited by 133
Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis
Corcia, P., Mayeux‐Portas, V., Khoris, J., de Toffol, B., Autret, A., Müh, J. P., Camu, W., & Andres, C. R. (2002) · Annals of Neurology · doi:10.1002/ana.10104 · Cited by 131
Beghi, E., Logroscino, G., Chiò, A., Hardiman, O. M., Millul, A., Mitchell, D. J., Swingler, R. J., & Traynor, B. J. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903384283 · Cited by 130
Night-time nasal ventilation in neuromuscular disease
Heckmatt, J. Z., Dubowitz, V., Loh, L., & Anaesth, F. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)90357-b · Cited by 129
Recent advances in the genetics of amyotrophic lateral sclerosis
Valdmanis, P. N., Daoud, H., Dion, P. A., & Rouleau, G. A. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0030-9 · Cited by 122
Amyotrophic Lateral Sclerosis in Sweden, 1991-2005
Fang, F., Valdimarsdóttir, U., Bellocco, R., Ronnevi, L.-O., Sparén, P., Fall, K., & Ye, W. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.13 · Cited by 119
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
Winer, L. K., Srinivasan, D., Chun, S. J., Lacomis, D., Jaffa, M., Fagan, A. M., Holtzman, D. M., Wancewicz, E. V., Bennett, C. F., Bowser, R. P., et al. (2012) · JAMA Neurology · doi:10.1001/jamaneurol.2013.593 · Cited by 119
Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction
Mitsumoto, H., Davidson, M., Moore, D. H., Gad, N. T. I., Brandis, M., Ringel, S. P., Rosenfeld, J., Shefner, J. M., Strong, M. J., Sufit, R. L., et al. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310011728 · Cited by 117
Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS
Limousin, N., Blasco, H., Corcia, P., Gordon, P. H., de Toffol, B., Andres, C. R., & Praline, J. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.06.028 · Cited by 113
Self-citationLudolph, A. C., Bendotti, C., Blaugrund, E., Hengerer, B., Loeffler, J., Martin, J. E., Meininger, V., Meyer, T., Moussaoui, S. M., Robberecht, W., et al. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701292837 · Cited by 113
Gordon, P. H., Miller, R. G., & Moore, D. H. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/17434470410019906 · Cited by 109
Self-citationPhenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations
Corcia, P., Valdmanis, P. N., Millecamps, S., Lionnet, C., Blasco, H., Mouzat, K., Daoud, H., Belzil, V., Morales, R. J., Pageot, N., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182553c88 · Cited by 102
The epidemiology of ALS in Modena, Italy
Mandrioli, J., FAGLIONI, P., Merelli, E., & Sola, P. (2003) · Neurology · doi:10.1212/01.wnl.0000048208.54755.78 · Cited by 101
Muscle Nogo‐a expression is a prognostic marker in lower motor neuron syndromes
Pradat, P., Bruneteau, G., de Aguilar, J. G., Dupuis, L., Jokic, N., Salachas, F., Forestier, N. L., Echaniz‐Laguna, A., Dubourg, O., Hauw, J., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21122 · Cited by 98
A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS
Levy, G., Kaufmann, P., Buchsbaum, R., Montes, J., Barsdorf, A. I., Arbing, R. H. A., Battista, V., Zhou, X., Mitsumoto, H., Levin, B., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000201182.60750.66 · Cited by 98
Majoor‐Krakauer, D. F., Ottman, R., Johnson, W. G., & Rowland, L. P. (1994) · Neurology · doi:10.1212/wnl.44.10.1872 · Cited by 98
Otto, M., Bowser, R. P., Turner, M. R., Berry, J. D., Brettschneider, J., Connor, J. R., Costa, J., Cudkowicz, M., Glass, J. D., Jahn, O., et al. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.627589 · Cited by 93
Genetics of familial ALS and consequences for diagnosis
Camu, W., Khoris, J., Moulard, B., Salachas, F., Briolotti, V., Rouleau, G. A., & Meininger, V. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00022-2 · Cited by 92
Mulligan, V. K., & Chakrabartty, A. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24285 · Cited by 91
ALS Drug Development: Reflections from the Past and a Way Forward
Aggarwal, S., & Cudkowicz, M. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.08.002 · Cited by 88
Functional electrical stimulation therapies after spinal cord injury
Gater, D. R., Dolbow, D. R., Tsui, B., & Gorgey, A. S. (2011) · Neurorehabilitation · doi:10.3233/nre-2011-0652 · Cited by 86
Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease
Bello-Haas, V. P. M. D., Florence, J. M., & Krivickas, L. S. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005229.pub2 · Cited by 86
Toward more efficient clinical trials for amyotrophic lateral sclerosis
Cudkowicz, M., Katz, J., Moore, D. H., O’Neill, G. N., Glass, J. D., Mitsumoto, H., Appel, S. H., Ravina, B. M., Kieburtz, K. D., Shoulson, I., et al. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903358865 · Cited by 81
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS
Gordon, P. H., Cheung, Y. K., Levin, B. L., Andrews, H., Doorish, C., MacArthur, R. B., Montes, J., Bednarz, K., Florence, J. M., Rowin, J., et al. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802195632 · Cited by 80
Self-citationMeasures and markers in Amyotrophic Lateral Sclerosis
Cudkowicz, M., Qureshi, M., & Shefner, J. M. (2004) · Neurotherapeutics · doi:10.1602/neurorx.1.2.273 · Cited by 79
Gordon, P. H., Delgadillo, D., Piquard, A., Bruneteau, G., Pradat, P., Salachas, F., Payan, C., Meininger, V., & Lacomblez, L. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.580847 · Cited by 79
Self-citationTargeting the Nogo-A Signalling Pathway to Promote Recovery Following Acute CNS Injury
Walmsley, A. R., & Mir, A. K. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781368611 · Cited by 77
Kurland, L. T., Hirano, A., Malamud, N., & Lessell, S. (1961) · PubMed · Cited by 67
Prognostic factors in ALS: A critical review
Chiò, A., Logroscino, G., Hardiman, O. M., Swingler, R. J., Mitchell, D. J., Beghi, E., Traynor, B. J., & On Behalf of the EURALS Consortium (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802566824 · Cited by 66
Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial
Leigh, P. N., Swash, M., Iwasaki, Y., Ludolph, A. C., Meininger, V., Miller, R. G., Mitsumoto, H., Shaw, P. J., Tashiro, K., & van den Berg, L. H. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820410020187 · Cited by 65
Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS
Diekstra, F. P., Saris, C. G. J., van Rheenen, W., Franke, L., Jansen, R. C., van Es, M. A., van Vught, P. W. J., Blauw, H. M., Groen, E. J. N., Horvath, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035333 · Cited by 64
How can we improve clinical trials in amyotrophic lateral sclerosis?
Gordon, P. H., & Meininger, V. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.147 · Cited by 61
Self-citationHow common is depression among ALS caregivers? A longitudinal study
Rabkin, J. G., Albert, S. M., Rowland, L. P., & Mitsumoto, H. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802459889 · Cited by 60
Research Advances in Amyotrophic Lateral Sclerosis, 2009 to 2010
Traub, R., Mitsumoto, H., & Rowland, L. P. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0160-0 · Cited by 55
Gordon, P. H., Salachas, F., Lacomblez, L., Forestier, N. L., Pradat, P., Bruneteau, G., Elbaz, A., & Meininger, V. (2012) · Neurodegenerative Diseases · doi:10.1159/000341316 · Cited by 55
Self-citationIncidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007
Marin, B., Gil, J., Preux, P., Funalot, B., & Couratier, P. (2009) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960902721626 · Cited by 54
Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis
Lechtzin, N., Wiener, C. M., Clawson, L., Davidson, M. C., Anderson, F. A., Gowda, N., Diette, G. B., & the ALS CARE Study Group (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310017335 · Cited by 53
How common is depression among ALS caregivers? A longitudinal study
Rabkin, J. G., Albert, S. M., Rowland, L. P., & Mitsumoto, H. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802459889 · Cited by 53
Defining Survival as an Outcome Measure in Amyotrophic Lateral Sclerosis
Gordon, P. H., Corcia, P., Lacomblez, L., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.1 · Cited by 51
Self-citationAggregation of neurodegenerative disease in ALS kindreds
Fallis, B. A., & Hardiman, O. M. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802209664 · Cited by 50
SELECTING PROMISING ALS THERAPIES IN CLINICAL TRIALS
Glass, J. D., Benatar, M. G., & Polak, M. A. (2007) · Neurology · doi:10.1212/01.wnl.0000265319.46474.f6 · Cited by 45
Amyotrophic lateral sclerosis progression and stability of brain-computer interface communication
Silvoni, S., Cavinato, M., Volpato, C., Ruf, C. A., Birbaumer, N., & Piccione, F. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.770029 · Cited by 44
Selecting promising ALS therapies in clinical trials
Cheung, Y. K., Gordon, P. H., & Levin, B. L. (2006) · Neurology · doi:10.1212/01.wnl.0000244464.73221.13 · Cited by 43
Self-citation(2009) · Neurology · doi:10.1212/wnl.0b013e3181c9bef1 · Cited by 41
Incidence of Amyotrophic Lateral Sclerosis Among American Indians and Alaska Natives
Gordon, P. H., Mehal, J. M., Holman, R. C., Rowland, L. P., Rowland, A. S., & Cheek, J. E. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.929 · Cited by 39
Self-citationTHE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS WITH VITAMIN E (TOCOPHEROLS)
Wechsler, I. S. (1940) · The American Journal of the Medical Sciences · doi:10.1097/00000441-194012000-00005 · Cited by 35
Neuroprotective agents for clinical trials in Parkinson’s disease: A systematic assessment
Diguet, E., Gross, C. E., Bézard, E., Tison, F., Stefanova, N., & Wenning, G. K. (2004) · Neurology · doi:10.1212/wnl.62.1.158 · Cited by 35
Translating preclinical insights into effective human trials in ALS
DiBernardo, A., & Cudkowicz, M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.007 · Cited by 34
Olfactory ensheathing glia injections in Beijing: Misleading patients with ALS
Chew, S., Khandji, A. G., Montes, J., Mitsumoto, H., & Gordon, P. H. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701419315 · Cited by 31
Self-citationHeiman-Patterson, T. D., & Miller, R. G. (2006) · Neurology · doi:10.1212/01.wnl.0000238978.69141.57 · Cited by 31
Ragonese, P., Filippini, G., Salemi, G., Beghi, E., Citterio, A., D’Alessandro, R., Marini, C., Monsurrò, M. R., Aiello, I., Morgante, L., et al. (2004) · Neuroepidemiology · doi:10.1159/000073978 · Cited by 28
Early symptom progression rate is related to ALS outcome: A prospective population-based study
Turner, M. R., & Al‐Chalabi, A. (2002) · Neurology · doi:10.1212/wnl.59.12.2012-a · Cited by 27
Neuroprotective agents for clinical trials in ALS: A systematic assessment
Burke, W. J. (2007) · Neurology · doi:10.1212/01.wnl.0000258815.56062.43 · Cited by 25
Abdelnour-Mallet, M., Verschueren, A., Guy, N., Soriani, M., Chalbi, M., Gordon, P., Salachas, F., Bruneteau, G., Forestier, N. L., Lenglet, T., et al. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.531741 · Cited by 24
Self-citationIs there a case for diaphragm pacing for amyotrophic lateral sclerosis patients?
Amirjani, N., Kiernan, M. C., McKenzie, D. K., Butler, J. E., & Gandevia, S. C. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2012.673169 · Cited by 23
Diaphragm pacing in amyotrophic lateral sclerosis: A literature review
Scherer, K. H., & Bedlack, R. (2012) · Muscle & Nerve · doi:10.1002/mus.23419 · Cited by 23
When did Lou Gehrig's personal illness begin?
Kasarskis, E. J., & Winslow, M. (1989) · Neurology · doi:10.1212/wnl.39.9.1243 · Cited by 23
Chapter 20 Symptomatic therapy and palliative aspects of clinical care
Gordon, P. H., & Mitsumoto, H. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)80023-6 · Cited by 22
Self-citationDesigning Clinical Trials in Amyotrophic Lateral Sclerosis
Shefner, J. M. (2008) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2008.02.002 · Cited by 21
Stem cells and the ALS neurologist
Maragakis, N. J. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.489116 · Cited by 18
Amyotrophic lateral sclerosis and viruses.
Salazar‐Grueso, E. F., & Rp, R. (1995) · PubMed · Cited by 18
Cigarettes and amyotrophic lateral sclerosis: Only smoke or also fire?
Weisskopf, M. G., & Ascherio, A. (2009) · Annals of Neurology · doi:10.1002/ana.21700 · Cited by 17
Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review
Sutedja, N. A., Veldink, J. H., Fischer, K., Kromhout, H., Heederik, D. J. J., Huisman, M., Wokke, J. H. J., & van den Berg, L. H. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802455416 · Cited by 14
Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998
Chiò, A., Mora, G., Mutani, R., & Schiffer, D. (2003) · Neurology · doi:10.1212/wnl.60.9.1560 · Cited by 10
Fatigue and depression are associated with poor quality of life in ALS
Abe, K. (2004) · Neurology · doi:10.1212/wnl.62.10.1914 · Cited by 10
Lam, B. L. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.1665 · Cited by 8
Cited by
Amyotrophic Lateral Sclerosis: A Focus on Disease Progression
Calvo, A. C., Manzano, R., Mendonça, D. M. F., Muñoz, M. J., Zaragoza, P., & Osta, R. (2014) · BioMed Research International · doi:10.1155/2014/925101 · Cited by 403
Altered Proteins in the Aging Brain
Elobeid, A., Libard, S., Leino, M., Popova, S. N., & Alafuzoff, I. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw002 · Cited by 202
Dupont, A.-C., Largeau, B., Santiago Ribeiro, M., Guilloteau, D., Tronel, C., & Arlicot, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040785 · Cited by 182
Glia in the pathogenesis of neurodegenerative diseases
Verkhratsky, A., Parpura, V., Pekna, M., Pekny, M., & Sofroniew, M. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140107 · Cited by 141
Fan, W., Liang, C., Ou, M., Zou, T., Sun, F., Zhou, H., & Cui, L. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00090 · Cited by 116
Metadata
- Authors
- AP-HP, H. D. L. P.-S., & Gordon, P.
- Venue
- Aging and Disease
- Publisher
- Aging and Disease
- Published
- 2013
- Volume
- 04
- Issue
- 05
- Pages
- 295-310
- ISSN
- 2152-5250 (ISSN-L)
- OpenAlex
- W2171305248
- Cited by
- 277
- References
- 136
- FWCI
- 21.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.